The Biotechnology Innovation Organization (BIO) is a trade association representing biopharmaceutical companies. It lobbies Congress on Medicare and Medicaid reimbursement rules (including Medicare Part B and Part D), drug pricing policies such as Most Favored Nation proposals and the 340B program, patent and pharmacy benefit manager issues, and select national defense measures tied to biotech security. Its filings show recent work on the BIOSECURE Act and other drug-access legislation.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
mr STEVEN E IRIZARRY
The latest disclosures for this client.
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Q3ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Q2The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
VINCENT A. ROBERTI, SR.
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
CASEY DAVISON
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Q1ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Q4ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Q3ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Q2ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
Q1